Meloxicam
- Generic Name
- Meloxicam
- Brand Names
- Anjeso, Mobic, Qmiiz, Vivlodex
- Drug Type
- Small Molecule
- Chemical Formula
- C14H13N3O4S2
- CAS Number
- 71125-38-7
- Unique Ingredient Identifier
- VG2QF83CGL
- Background
Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve various types of pain, including pain caused by musculoskeletal conditions, osteoarthritis, and rheumatoid arthritis. With a longer half-life than most other NSAIDS, it is a favorable option for those who require once-daily dosing. Meloxicam is available in oral, transdermal, and intr...
- Indication
Meloxicam is indicated for the symptomatic treatment of arthritis and osteoarthritis. In addition, it is indicated for the pauciarticular and polyarticular course of Juvenile Rheumatoid Arthritis (JRA) in patients aged 2 years old or above. Off-label uses include the treatment of dental or post-surgical pain. In addition to the above, meloxicam has also been...
- Associated Conditions
- Dental Pain, Neuropathic Pain, Osteoarthritis (OA), Pain, Inflammatory, Pauciarticular juvenile rheumatoid arthritis, Polyarticular juvenile rheumatoid arthritis, chronic or unspecified, Postoperative pain, Rheumatoid Arthritis
- Associated Therapies
- -
Efficacy and Safety of Injectable Association of Dexamethasone, Dipyrone and Hydrocobalamin in Lumbar Sciatic Pain
- First Posted Date
- 2010-06-22
- Last Posted Date
- 2012-05-15
- Lead Sponsor
- Eurofarma Laboratorios S.A.
- Target Recruit Count
- 280
- Registration Number
- NCT01147289
- Locations
- 🇧🇷
Hospital Santa Marcelina, São Paulo, Brazil
🇧🇷Instituto De Pesquisa Clínica De Campinas IPECC, Campinas, São Paulo, Brazil
🇧🇷Sociedade Beneficente São Camilo, Campinas, São Paulo, Brazil
A Comparative Study of Tramadol Hydrochloride Plus Acetaminophen Tablets Maintenance Versus Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Maintenance in Participants With Knee Osteoarthritis
- Conditions
- Interventions
- First Posted Date
- 2008-03-13
- Last Posted Date
- 2013-07-22
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 143
- Registration Number
- NCT00635349
Bioequivalency Study of Meloxicam Tablets Under Fasting Conditions
- Conditions
- First Posted Date
- 2008-02-18
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 47
- Registration Number
- NCT00618163
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Houston, Texas, United States
Bioequivalency Study of Meloxicam Tablets Under Fed Conditions
- Conditions
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 48
- Registration Number
- NCT00601887
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Houston, Texas, United States
Mobicox: Study of Meloxicam to Reduce Prostate Swelling in Permanent Seed Prostate Brachytherapy
- Conditions
- First Posted Date
- 2005-09-09
- Last Posted Date
- 2010-08-13
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 100
- Registration Number
- NCT00152919
- Locations
- 🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada
A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis
- Conditions
- First Posted Date
- 2002-07-24
- Last Posted Date
- 2013-11-01
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 1000
- Registration Number
- NCT00042068
- Locations
- 🇺🇸
Suite 202, Kalamazoo, Michigan, United States
🇺🇸Suite 140, Anchorage, Alaska, United States
🇺🇸Suite 200, Dallas, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.